American Century Companies’s Alder Biopharmaceuticals ALDR Stock Holding History

American Century Companies’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200,940	Closed	-$2.37M	–	1389
2019 Q2	$2.37M	Buy	200,940 +54,719	+37%	+$662K	﹤0.01%	1002
2019 Q1	$2M	Sell	146,221 -7,166	-5%	-$92.8K	﹤0.01%	995
2018 Q4	$1.57M	Sell	153,387 -18,589	-11%	-$238K	﹤0.01%	1008
2018 Q3	$2.86M	Sell	171,976 -1,259	-0.7%	-$22.8K	﹤0.01%	964
2018 Q2	$2.74M	Buy	173,235 +62,704	+57%	+$953K	﹤0.01%	962
2018 Q1	$1.4M	Buy	110,531 +8,258	+8%	+$119K	﹤0.01%	1047
2017 Q4	$1.17M	Sell	102,273 -458	-0.4%	-$5.11K	﹤0.01%	1078
2017 Q3	$1.26M	Buy	102,731 +11,679	+13%	+$122K	﹤0.01%	1111
2017 Q2	$1.04M	Buy	91,052 +20,566	+29%	+$380K	﹤0.01%	1135
2017 Q1	$1.47M	Buy	70,486 +3,815	+6%	+$84.5K	﹤0.01%	1091
2016 Q4	$1.39M	Sell	66,671 -13,827	-17%	-$360K	﹤0.01%	1088
2016 Q3	$2.64M	Buy	80,498 +3,254	+4%	+$99.1K	﹤0.01%	1018
2016 Q2	$1.93M	Buy	77,244 +4,274	+6%	+$116K	﹤0.01%	1032
2016 Q1	$1.79M	Sell	72,970 -2,767	-4%	-$64.1K	﹤0.01%	1025
2015 Q4	$2.5M	Buy	75,737 +6,829	+10%	+$231K	﹤0.01%	989
2015 Q3	$2.26M	Buy	68,908 +5,925	+9%	+$252K	﹤0.01%	1001
2015 Q2	$3.34M	Sell	62,983 -12,353	-16%	-$449K	﹤0.01%	949
2015 Q1	$2.17M	Buy	+75,336	New	+$2.07M	﹤0.01%	1031

Other funds holding ALDR

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies's ALDR Position: Q3 2019 in Review

American Century Companies sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 200,940 shares — an estimated $2.37M sold.

American Century Companies first reported a position in ALDR in Q1 2015 and held it in 18 quarters. The position peaked at $3.34M in Q2 2015. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

American Century Companies reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
American Century Companies sold 200,940 Alder Biopharmaceuticals shares in Q3 2019, an estimated $2.37M.
American Century Companies first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 18 quarters.
American Century Companies's Alder Biopharmaceuticals position peaked at $3.34M in Q2 2015.
143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.